Searle’s Denosumab biosimilar gains regulatory approval

News Image

MG News | September 10, 2025 at 01:08 PM GMT+05:00

September 10, 2025 (MLN): Searle Company Limited has reached a major milestone as Denosumab, Pakistan’s first biosimilar of its kind, receives regulatory approval. 

This development marked a transformative moment in the country’s pharmaceutical sector as it introduced a locally developed biotechnological therapy that expands access and affordability for patients nationwide.

Denosumab, a monoclonal antibody used to treat osteoporosis and cancer-related bone conditions, now enters the market in biosimilar form, offering a cost-effective alternative to imported treatments.

Patients previously burdened by high prices may now benefit from the broader availability of this advanced therapy.

“This approval reflects a commitment to innovation and patient-focused healthcare,” the company stated. “It signals progress toward greater accessibility and long-term value creation.”

It will potentially reshape the biotech landscape and encourage investment in local research and manufacturing.

Copyright Mettis Link News

Related News

Name Price/Vol %Chg/NChg
KSE100 170,471.79
164.02M
0.90%
1518.08
ALLSHR 102,846.03
619.51M
0.92%
933.03
KSE30 50,824.28
53.47M
0.94%
473.78
KMI30 243,745.15
50.63M
0.95%
2286.47
KMIALLSHR 66,713.18
255.86M
0.85%
560.93
BKTi 46,299.16
10.27M
1.07%
491.32
OGTi 35,125.96
4.22M
0.62%
217.71
Symbol Bid/Ask High/Low
Name Last High/Low Chg/%Chg
BITCOIN FUTURES 62,825.00 63,845.00
62,515.00
-650.00
-1.02%
BRENT CRUDE 92.21 94.42
92.00
-2.04
-2.16%
RICHARDS BAY COAL MONTHLY 124.00 124.00
124.00
-1.00
-0.80%
ROTTERDAM COAL MONTHLY 136.75 0.00
0.00
0.00
0.00%
USD RBD PALM OLEIN 1,157.50 1,157.50
1,157.50
0.00
0.00%
CRUDE OIL - WTI 89.01 91.55
88.80
-2.29
-2.51%
SUGAR #11 WORLD 14.08 14.23
14.06
-0.04
-0.28%

Chart of the Day


Latest News

Top 5 things to watch in this week

Pakistan Stock Movers
Name Last Chg/%Chg
Name Last Chg/%Chg